M7824 (bintrafusp alfa)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for M7824 (bintrafusp alfa), covering 2023-08-08 to 2024-05-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of M7824 and Paclitaxel Combination as a Second-line Treatment in Patients With Recurrent/Metastatic Gastric Cancer [Phase 1, Phase 2]